Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma for COVID-19 post-exposure prophylaxis
NCT04323800Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of anti-SARS-CoV-2 plasma in coronavirus disease 2019 (COVID-19), sponsored by Johns Hopkins University. Started Jun 2020; status: completed.
02
Drugs
anti-SARS-CoV-2 plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04323800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04323800.